Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Open in API
Filings indexed 1,418 across all filing types
Latest filing 2019-10-14 Legal Proceedings Report
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
MorphoSys and I-Mab Biopharma Announce IND Clearance to Initiate Clinical Trials of MOR202/TJ202 for the Treatment of Multiple Myeloma in Mainland China (news with additional features)
Legal Proceedings Report Classification · 99% confidence The document is a news release dated October 14, 2019, announcing that MorphoSys and I-Mab Biopharma received IND clearance from the NMPA to initiate clinical trials in China for the drug MOR202/TJ202. It contains details about a partnership, clinical trial expansion, and scientific background. This type of announcement, detailing a specific corporate event (a regulatory clearance for a drug trial expansion) that is not a full financial report (like 10-K or IR), nor a management change (MANG), nor a dividend announcement (DIV), fits best under the general category for regulatory/corporate news that doesn't fit elsewhere, which is Regulatory Filings (RNS). Although it is a specific corporate update, it is structured as a news release disseminated via DGAP, which often serves as a catch-all for important, non-standardized corporate news. Given the options, RNS is the most appropriate general regulatory news category for this specific clinical/regulatory milestone announcement.
2019-10-14 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Notification of Major Holdings' and details changes in voting rights percentages (from 3.03% to 7.58%) held by Invesco Ltd. and its subsidiaries in MorphoSys AG, referencing German Securities Trading Act (WpHG) articles. This type of filing, which reports changes in significant share ownership thresholds, directly corresponds to the definition of Major Shareholding Notification. The code for this is MRQ.
2019-10-11 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership ('Notification of Major Holdings'). It specifies the date the threshold was crossed (24 May 2019) and the new total voting rights percentage (4.56%). This content directly aligns with the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing regulatory thresholds. The code for this is MRQ.
2019-10-11 English
DGAP-DD: MorphoSys AG english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section titled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details a transaction involving a Member of the managing body (Dr. Jean-Paul Kress) and the acceptance of stock options. This directly corresponds to the definition of Director's Dealing, which is classified under the code DIRS.
2019-10-09 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German Securities Trading Act (WpHG) regulations. It details changes in the percentage of voting rights held by Baillie Gifford & Co, crossing a threshold (from 3.90% to 6.26%). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels. Although the document mentions 'Voting Rights Announcements' in the header, the core content is the notification of a change in major shareholding percentage, which maps precisely to the 'Major Shareholding Notification' category (MRQ). It is not an AGM-R, DEF 14A (Remuneration), or DVA (Voting Results), but a notification about ownership thresholds.
2019-10-08 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a 'Total Voting Rights Announcement' published by MorphoSys AG, referencing Article 41 of the WpHG (German Securities Trading Act). It explicitly details a 'Type of capital measure' which is a 'Conditional capital increase' and states the 'New total number of voting rights' as 31,927,958, effective September 30, 2019. This type of announcement, dealing with changes in the total number of shares/voting rights due to capital structure events (like conditional capital increases), fits best under the 'Share Issue/Capital Change' category (SHA). It is not a general earnings release (ER), a full annual report (10-K), or a director's dealing (DIRS).
2019-09-30 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.